Twitter  |    LinkedIn

Innovation matters in dermatology

Now Viewing Articles

Advancing Innovation in Dermatology is pleased to make available our collection of scholar articles, industry news, and interviews with the professionals accelerating innovation in skin health and patient care. This content is yet another way beyond our in-person and virtual events to strengthen the community of innovators we aim to build and maintain.

Sep 11, 2018
By: Advancing Innovation in Dermatology

READ FULL ARTICLE | Dermatology Times

Introducing a new column called “Innovation” from the co-founders of Advancing Innovation in Dermatology Accelerator Fund. In the first installment of this series, Drs. Steve Xu and William Ju address the importance of innovation in dermatology.

Dermatology is a small field, however, from an innovation standpoint, we have always felt that dermatology punches way above its weight1.

Over the last 20 years, the increased knowledge of the underlying pathophysiology of skin diseases has led to critical insights that have yielded new therapeutic options:

  • Our field continues to be at the forefront of clinical immunology with new targeted biologics providing dramatic disease responses for patients with serious inflammatory skin conditions.
  • In oncology, melanoma and Merkel cell carcinoma are focus points in cancer immunotherapy.
  • Non-invasive fat reduction, and laser/light and other energy-based products are bright spots in medical device innovation.
  • Breakthrough advances in gene therapy and stem cell science hold great promise in treating fatal blistering diseases.
  • Botulinum toxin and fillers, driven forward by dermatologists2, have fueled the increasing demand for non-invasive aesthetic treatments.
  • Finally, artificial intelligence and other health IT tools have already entered our field in meaningful ways.



1) Shuai Xu, MD; Jamie Breslin, PhD; William Ju, MD. “Catalyzing Future Drug, Device, and Information Technology Breakthroughs in Dermatology. Announcing Advancing Innovation in Dermatology’s Accelerator Fund,” JAMA Dermatology. May 2018. DOI:10.1001/jamadermatol.2018.0590

READ FULL ARTICLE | Dermatology Times